AtriaPRM wins €15,000 grant to automate clinical paperwork with AI
What's the deal? AtriaPRMDealroom has a profile for this one. Try Dealroom →, a Ukrainian healthtech startup, won a €15,000 (≈$16,805) non-equity grant from SET University and the Tokarev Foundation as the top prize of Generation H's third season. The company uses AI to turn unstructured medical documents — diagnostic reports, test results, and consultation notes — into structured clinical data.
What's the endgame? AtriaPRM aims to cut administrative overhead for healthcare facilities by automating clinical processes, patient communication, and treatment coordination. The grant money supports that push, though it is early-stage validation rather than venture-scale financing.
Why now? The final took place on September 10 in Kyiv, concluding a 10-week program that, for the first time, opened applications to teams outside Ukraine. This cohort ran within the EUNITED Digital Hub, co-funded by the European UnionDealroom has a profile for this one. Try Dealroom → under its Digital Europe programme.
The other winner: Enhance Your AbilityDealroom has a profile for this one. Try Dealroom → took a €5,000 Audience Choice Award for its AI platform supporting non-speaking children. It combines alternative communication tools, educational content, and support for parents, therapists, and schools. Three further finalists — TomoPulse, OBRIYDealroom has a profile for this one. Try Dealroom →, and PRMDealroom has a profile for this one. Try Dealroom → — also pitched at the demo day.
Generation H launched in 2024 as a national platform for Ukraine's healthtech ecosystem. Since then, more than 30 startups have completed the program, backed by over 60 mentors and lecturers; alumni have collectively raised more than UAH 11 million.
"Healthtech in Ukraine has ceased to be an experiment and has become an industry with its own leaders who are already expanding beyond the country's borders," said Serhii Tokarev, founder of the Tokarev Foundation and co-founder of SET University. He added that he wants "the next big healthtech company in the world to be born right here in Ukraine."
The signal: The grants are modest, but the recurring program and widened eligibility offer rare early support for founders building under pressure. Small, repeatable checks like these help keep Ukraine's healthtech pipeline moving while larger capital stays scarce.
Read more: newstrail.com
Image credit: Defence Images
